French molecular imaging firm Advanced Accelerator Applications (AAA) has signed a distribution deal for its Lutathera radiopharmaceutical with Fujifilm RI Pharma in Japan.
AAA will manufacture Lutathera in Europe and receive launch and development milestone payments as well as product sales royalties, according to the firm. The companies will work together to meet Japanese regulatory requirements and prepare for national approval, AAA said.
Lutathera is currently in a phase III trial in the U.S. and the European Union; results are expected in the first quarter.
